Summary

The global Allogeneic Universal Cell Therapy market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Allogeneic universal cells, also called off-the-shelf cells, refer to a type of cell therapy that uses cells from different individuals instead of the patient"s own cells for treatment.
In 2025, the North America Allogeneic Universal Cell Therapy market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Allogeneic Universal Cell Therapy include Novartis, Gilead Sciences, Yi Zun Biology, Bangyao Biotechnology, Usano, Cellectis, Allogene, Caribou, Poseida Therapeutics, Keji Pharmaceutical, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Allogeneic Universal Cell Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Novartis
Gilead Sciences
Yi Zun Biology
Bangyao Biotechnology
Usano
Cellectis
Allogene
Caribou
Poseida Therapeutics
Keji Pharmaceutical
Beiheng Biotechnology
Grace Biotechnology
Nkarta Therapeutic
Fate Therapeutics
Ruishun Biology
Cynata
Fate
Century
Cytovia
BeiGene
Cell-Origin
Neukio
Segment by Type
CAR-T cell therapy
Natural Universal Cell Therapy
Immune Cell Therapy
Segment by Application
Hematoma
Solid Tumor
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Allogeneic Universal Cell Therapy market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Allogeneic Universal Cell Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 CAR-T cell therapy
1.2.3 Natural Universal Cell Therapy
1.2.4 Immune Cell Therapy
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Hematoma
1.3.3 Solid Tumor
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Allogeneic Universal Cell Therapy Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Allogeneic Universal Cell Therapy Market Share by Revenue, by Region (2021-2026)
2.4 Global Allogeneic Universal Cell Therapy Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Allogeneic Universal Cell Therapy Market Size and Prospective (2021-2032)
2.5.2 Europe Allogeneic Universal Cell Therapy Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Allogeneic Universal Cell Therapy Market Size and Prospective (2021-2032)
2.5.4 Latin America Allogeneic Universal Cell Therapy Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Allogeneic Universal Cell Therapy Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Allogeneic Universal Cell Therapy Historical Market Size by Type (2021-2026)
3.2 Global Allogeneic Universal Cell Therapy Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Allogeneic Universal Cell Therapy

4 Breakdown Data by Application
4.1 Global Allogeneic Universal Cell Therapy Historical Market Size by Application (2021-2026)
4.2 Global Allogeneic Universal Cell Therapy Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Allogeneic Universal Cell Therapy Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Allogeneic Universal Cell Therapy Players by Revenue (2021-2026)
5.1.2 Global Allogeneic Universal Cell Therapy Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Allogeneic Universal Cell Therapy Revenue
5.4 Global Allogeneic Universal Cell Therapy Market Concentration Analysis
5.4.1 Global Allogeneic Universal Cell Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Allogeneic Universal Cell Therapy Revenue in 2025
5.5 Global Key Players of Allogeneic Universal Cell Therapy Head Offices and Areas Served
5.6 Global Key Players of Allogeneic Universal Cell Therapy, Product and Application
5.7 Global Key Players of Allogeneic Universal Cell Therapy, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Allogeneic Universal Cell Therapy Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Allogeneic Universal Cell Therapy Market Size by Type (2021-2026)
6.1.2.2 North America Allogeneic Universal Cell Therapy Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Allogeneic Universal Cell Therapy Market Size by Application (2021-2026)
6.1.3.2 North America Allogeneic Universal Cell Therapy Market Share by Application (2021-2026)
6.1.4 North America Allogeneic Universal Cell Therapy Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Allogeneic Universal Cell Therapy Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Allogeneic Universal Cell Therapy Market Size by Type (2021-2026)
6.2.2.2 Europe Allogeneic Universal Cell Therapy Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Allogeneic Universal Cell Therapy Market Size by Application (2021-2026)
6.2.3.2 Europe Allogeneic Universal Cell Therapy Market Share by Application (2021-2026)
6.2.4 Europe Allogeneic Universal Cell Therapy Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Allogeneic Universal Cell Therapy Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Allogeneic Universal Cell Therapy Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Allogeneic Universal Cell Therapy Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Allogeneic Universal Cell Therapy Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Allogeneic Universal Cell Therapy Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Allogeneic Universal Cell Therapy Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Allogeneic Universal Cell Therapy Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Allogeneic Universal Cell Therapy Market Size by Type (2021-2026)
6.4.2.2 Latin America Allogeneic Universal Cell Therapy Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Allogeneic Universal Cell Therapy Market Size by Application (2021-2026)
6.4.3.2 Latin America Allogeneic Universal Cell Therapy Market Share by Application (2021-2026)
6.4.4 Latin America Allogeneic Universal Cell Therapy Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Allogeneic Universal Cell Therapy Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Allogeneic Universal Cell Therapy Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Allogeneic Universal Cell Therapy Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Allogeneic Universal Cell Therapy Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Allogeneic Universal Cell Therapy Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Allogeneic Universal Cell Therapy Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 Novartis
7.1.1 Novartis Company Details
7.1.2 Novartis Business Overview
7.1.3 Novartis Allogeneic Universal Cell Therapy Introduction
7.1.4 Novartis Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.1.5 Novartis Recent Development
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Details
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Allogeneic Universal Cell Therapy Introduction
7.2.4 Gilead Sciences Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.2.5 Gilead Sciences Recent Development
7.3 Yi Zun Biology
7.3.1 Yi Zun Biology Company Details
7.3.2 Yi Zun Biology Business Overview
7.3.3 Yi Zun Biology Allogeneic Universal Cell Therapy Introduction
7.3.4 Yi Zun Biology Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.3.5 Yi Zun Biology Recent Development
7.4 Bangyao Biotechnology
7.4.1 Bangyao Biotechnology Company Details
7.4.2 Bangyao Biotechnology Business Overview
7.4.3 Bangyao Biotechnology Allogeneic Universal Cell Therapy Introduction
7.4.4 Bangyao Biotechnology Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.4.5 Bangyao Biotechnology Recent Development
7.5 Usano
7.5.1 Usano Company Details
7.5.2 Usano Business Overview
7.5.3 Usano Allogeneic Universal Cell Therapy Introduction
7.5.4 Usano Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.5.5 Usano Recent Development
7.6 Cellectis
7.6.1 Cellectis Company Details
7.6.2 Cellectis Business Overview
7.6.3 Cellectis Allogeneic Universal Cell Therapy Introduction
7.6.4 Cellectis Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.6.5 Cellectis Recent Development
7.7 Allogene
7.7.1 Allogene Company Details
7.7.2 Allogene Business Overview
7.7.3 Allogene Allogeneic Universal Cell Therapy Introduction
7.7.4 Allogene Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.7.5 Allogene Recent Development
7.8 Caribou
7.8.1 Caribou Company Details
7.8.2 Caribou Business Overview
7.8.3 Caribou Allogeneic Universal Cell Therapy Introduction
7.8.4 Caribou Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.8.5 Caribou Recent Development
7.9 Poseida Therapeutics
7.9.1 Poseida Therapeutics Company Details
7.9.2 Poseida Therapeutics Business Overview
7.9.3 Poseida Therapeutics Allogeneic Universal Cell Therapy Introduction
7.9.4 Poseida Therapeutics Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.9.5 Poseida Therapeutics Recent Development
7.10 Keji Pharmaceutical
7.10.1 Keji Pharmaceutical Company Details
7.10.2 Keji Pharmaceutical Business Overview
7.10.3 Keji Pharmaceutical Allogeneic Universal Cell Therapy Introduction
7.10.4 Keji Pharmaceutical Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.10.5 Keji Pharmaceutical Recent Development
7.11 Beiheng Biotechnology
7.11.1 Beiheng Biotechnology Company Details
7.11.2 Beiheng Biotechnology Business Overview
7.11.3 Beiheng Biotechnology Allogeneic Universal Cell Therapy Introduction
7.11.4 Beiheng Biotechnology Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.11.5 Beiheng Biotechnology Recent Development
7.12 Grace Biotechnology
7.12.1 Grace Biotechnology Company Details
7.12.2 Grace Biotechnology Business Overview
7.12.3 Grace Biotechnology Allogeneic Universal Cell Therapy Introduction
7.12.4 Grace Biotechnology Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.12.5 Grace Biotechnology Recent Development
7.13 Nkarta Therapeutic
7.13.1 Nkarta Therapeutic Company Details
7.13.2 Nkarta Therapeutic Business Overview
7.13.3 Nkarta Therapeutic Allogeneic Universal Cell Therapy Introduction
7.13.4 Nkarta Therapeutic Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.13.5 Nkarta Therapeutic Recent Development
7.14 Fate Therapeutics
7.14.1 Fate Therapeutics Company Details
7.14.2 Fate Therapeutics Business Overview
7.14.3 Fate Therapeutics Allogeneic Universal Cell Therapy Introduction
7.14.4 Fate Therapeutics Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.14.5 Fate Therapeutics Recent Development
7.15 Ruishun Biology
7.15.1 Ruishun Biology Company Details
7.15.2 Ruishun Biology Business Overview
7.15.3 Ruishun Biology Allogeneic Universal Cell Therapy Introduction
7.15.4 Ruishun Biology Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.15.5 Ruishun Biology Recent Development
7.16 Cynata
7.16.1 Cynata Company Details
7.16.2 Cynata Business Overview
7.16.3 Cynata Allogeneic Universal Cell Therapy Introduction
7.16.4 Cynata Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.16.5 Cynata Recent Development
7.17 Fate
7.17.1 Fate Company Details
7.17.2 Fate Business Overview
7.17.3 Fate Allogeneic Universal Cell Therapy Introduction
7.17.4 Fate Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.17.5 Fate Recent Development
7.18 Century
7.18.1 Century Company Details
7.18.2 Century Business Overview
7.18.3 Century Allogeneic Universal Cell Therapy Introduction
7.18.4 Century Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.18.5 Century Recent Development
7.19 Cytovia
7.19.1 Cytovia Company Details
7.19.2 Cytovia Business Overview
7.19.3 Cytovia Allogeneic Universal Cell Therapy Introduction
7.19.4 Cytovia Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.19.5 Cytovia Recent Development
7.20 BeiGene
7.20.1 BeiGene Company Details
7.20.2 BeiGene Business Overview
7.20.3 BeiGene Allogeneic Universal Cell Therapy Introduction
7.20.4 BeiGene Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.20.5 BeiGene Recent Development
7.21 Cell-Origin
7.21.1 Cell-Origin Company Details
7.21.2 Cell-Origin Business Overview
7.21.3 Cell-Origin Allogeneic Universal Cell Therapy Introduction
7.21.4 Cell-Origin Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.21.5 Cell-Origin Recent Development
7.22 Neukio
7.22.1 Neukio Company Details
7.22.2 Neukio Business Overview
7.22.3 Neukio Allogeneic Universal Cell Therapy Introduction
7.22.4 Neukio Revenue in Allogeneic Universal Cell Therapy Business (2021-2026)
7.22.5 Neukio Recent Development

8 Allogeneic Universal Cell Therapy Market Dynamics
8.1 Allogeneic Universal Cell Therapy Industry Trends
8.2 Allogeneic Universal Cell Therapy Market Drivers
8.3 Allogeneic Universal Cell Therapy Market Challenges
8.4 Allogeneic Universal Cell Therapy Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Allogeneic Universal Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Allogeneic Universal Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Allogeneic Universal Cell Therapy Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Allogeneic Universal Cell Therapy Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Allogeneic Universal Cell Therapy Revenue Share by Region (2021-2026)
Table 6. Global Allogeneic Universal Cell Therapy Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Allogeneic Universal Cell Therapy Revenue Share Forecast by Region (2027-2032)
Table 8. Global Allogeneic Universal Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Allogeneic Universal Cell Therapy Market Share by Revenue, by Type (2021-2026)
Table 10. Global Allogeneic Universal Cell Therapy Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Allogeneic Universal Cell Therapy Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Allogeneic Universal Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Allogeneic Universal Cell Therapy Market Share by Revenue, by Application (2021-2026)
Table 15. Global Allogeneic Universal Cell Therapy Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Allogeneic Universal Cell Therapy Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Allogeneic Universal Cell Therapy Applications
Table 18. Global Allogeneic Universal Cell Therapy Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Allogeneic Universal Cell Therapy Market Share by Players (2021-2026)
Table 20. Global Top Allogeneic Universal Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Universal Cell Therapy as of 2025)
Table 21. Ranking of Global Top Allogeneic Universal Cell Therapy Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Allogeneic Universal Cell Therapy Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Allogeneic Universal Cell Therapy, Headquarters and Area Served
Table 24. Global Key Players of Allogeneic Universal Cell Therapy, Product and Application
Table 25. Global Key Players of Allogeneic Universal Cell Therapy, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Allogeneic Universal Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Allogeneic Universal Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 29. North America Allogeneic Universal Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Allogeneic Universal Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Allogeneic Universal Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Allogeneic Universal Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Allogeneic Universal Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Allogeneic Universal Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Allogeneic Universal Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Allogeneic Universal Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Allogeneic Universal Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Allogeneic Universal Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Allogeneic Universal Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Allogeneic Universal Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Allogeneic Universal Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Allogeneic Universal Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Allogeneic Universal Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Allogeneic Universal Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Allogeneic Universal Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Allogeneic Universal Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Allogeneic Universal Cell Therapy Product
Table 50. Novartis Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. Gilead Sciences Company Details
Table 53. Gilead Sciences Business Overview
Table 54. Gilead Sciences Allogeneic Universal Cell Therapy Product
Table 55. Gilead Sciences Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 56. Gilead Sciences Recent Development
Table 57. Yi Zun Biology Company Details
Table 58. Yi Zun Biology Business Overview
Table 59. Yi Zun Biology Allogeneic Universal Cell Therapy Product
Table 60. Yi Zun Biology Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 61. Yi Zun Biology Recent Development
Table 62. Bangyao Biotechnology Company Details
Table 63. Bangyao Biotechnology Business Overview
Table 64. Bangyao Biotechnology Allogeneic Universal Cell Therapy Product
Table 65. Bangyao Biotechnology Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 66. Bangyao Biotechnology Recent Development
Table 67. Usano Company Details
Table 68. Usano Business Overview
Table 69. Usano Allogeneic Universal Cell Therapy Product
Table 70. Usano Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 71. Usano Recent Development
Table 72. Cellectis Company Details
Table 73. Cellectis Business Overview
Table 74. Cellectis Allogeneic Universal Cell Therapy Product
Table 75. Cellectis Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 76. Cellectis Recent Development
Table 77. Allogene Company Details
Table 78. Allogene Business Overview
Table 79. Allogene Allogeneic Universal Cell Therapy Product
Table 80. Allogene Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 81. Allogene Recent Development
Table 82. Caribou Company Details
Table 83. Caribou Business Overview
Table 84. Caribou Allogeneic Universal Cell Therapy Product
Table 85. Caribou Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 86. Caribou Recent Development
Table 87. Poseida Therapeutics Company Details
Table 88. Poseida Therapeutics Business Overview
Table 89. Poseida Therapeutics Allogeneic Universal Cell Therapy Product
Table 90. Poseida Therapeutics Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 91. Poseida Therapeutics Recent Development
Table 92. Keji Pharmaceutical Company Details
Table 93. Keji Pharmaceutical Business Overview
Table 94. Keji Pharmaceutical Allogeneic Universal Cell Therapy Product
Table 95. Keji Pharmaceutical Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 96. Keji Pharmaceutical Recent Development
Table 97. Beiheng Biotechnology Company Details
Table 98. Beiheng Biotechnology Business Overview
Table 99. Beiheng Biotechnology Allogeneic Universal Cell Therapy Product
Table 100. Beiheng Biotechnology Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 101. Beiheng Biotechnology Recent Development
Table 102. Grace Biotechnology Company Details
Table 103. Grace Biotechnology Business Overview
Table 104. Grace Biotechnology Allogeneic Universal Cell Therapy Product
Table 105. Grace Biotechnology Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 106. Grace Biotechnology Recent Development
Table 107. Nkarta Therapeutic Company Details
Table 108. Nkarta Therapeutic Business Overview
Table 109. Nkarta Therapeutic Allogeneic Universal Cell Therapy Product
Table 110. Nkarta Therapeutic Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 111. Nkarta Therapeutic Recent Development
Table 112. Fate Therapeutics Company Details
Table 113. Fate Therapeutics Business Overview
Table 114. Fate Therapeutics Allogeneic Universal Cell Therapy Product
Table 115. Fate Therapeutics Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 116. Fate Therapeutics Recent Development
Table 117. Ruishun Biology Company Details
Table 118. Ruishun Biology Business Overview
Table 119. Ruishun Biology Allogeneic Universal Cell Therapy Product
Table 120. Ruishun Biology Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 121. Ruishun Biology Recent Development
Table 122. Cynata Company Details
Table 123. Cynata Business Overview
Table 124. Cynata Allogeneic Universal Cell Therapy Product
Table 125. Cynata Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 126. Cynata Recent Development
Table 127. Fate Company Details
Table 128. Fate Business Overview
Table 129. Fate Allogeneic Universal Cell Therapy Product
Table 130. Fate Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 131. Fate Recent Development
Table 132. Century Company Details
Table 133. Century Business Overview
Table 134. Century Allogeneic Universal Cell Therapy Product
Table 135. Century Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 136. Century Recent Development
Table 137. Cytovia Company Details
Table 138. Cytovia Business Overview
Table 139. Cytovia Allogeneic Universal Cell Therapy Product
Table 140. Cytovia Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 141. Cytovia Recent Development
Table 142. BeiGene Company Details
Table 143. BeiGene Business Overview
Table 144. BeiGene Allogeneic Universal Cell Therapy Product
Table 145. BeiGene Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 146. BeiGene Recent Development
Table 147. Cell-Origin Company Details
Table 148. Cell-Origin Business Overview
Table 149. Cell-Origin Allogeneic Universal Cell Therapy Product
Table 150. Cell-Origin Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 151. Cell-Origin Recent Development
Table 152. Neukio Company Details
Table 153. Neukio Business Overview
Table 154. Neukio Allogeneic Universal Cell Therapy Product
Table 155. Neukio Revenue in Allogeneic Universal Cell Therapy Business (2021-2026) & (US$ Million)
Table 156. Neukio Recent Development
Table 157. Allogeneic Universal Cell Therapy Market Trends
Table 158. Allogeneic Universal Cell Therapy Market Drivers
Table 159. Allogeneic Universal Cell Therapy Market Challenges
Table 160. Allogeneic Universal Cell Therapy Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources

List of Figures
Figure 1. Allogeneic Universal Cell Therapy Product Picture
Figure 2. Global Allogeneic Universal Cell Therapy Market Share by Type: 2025 vs 2032
Figure 3. CAR-T cell therapy Features
Figure 4. Natural Universal Cell Therapy Features
Figure 5. Immune Cell Therapy Features
Figure 6. Global Allogeneic Universal Cell Therapy Market Share by Application: 2025 vs 2032
Figure 7. Hematoma
Figure 8. Solid Tumor
Figure 9. Allogeneic Universal Cell Therapy Report Years Considered
Figure 10. Global Allogeneic Universal Cell Therapy Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 11. Global Allogeneic Universal Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Allogeneic Universal Cell Therapy Market Share by Revenue, by Region: 2021 vs 2025
Figure 13. North America Allogeneic Universal Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 14. Europe Allogeneic Universal Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Asia-Pacific Allogeneic Universal Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Latin America Allogeneic Universal Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Middle East & Africa Allogeneic Universal Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Global Allogeneic Universal Cell Therapy Market Share by Players in 2025
Figure 19. Global Top Allogeneic Universal Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Universal Cell Therapy as of 2025)
Figure 20. The Top 10 and 5 Players Market Share by Allogeneic Universal Cell Therapy Revenue in 2025
Figure 21. North America Allogeneic Universal Cell Therapy Market Share by Type (2021-2026)
Figure 22. North America Allogeneic Universal Cell Therapy Market Share by Application (2021-2026)
Figure 23. Europe Allogeneic Universal Cell Therapy Market Share by Type (2021-2026)
Figure 24. Europe Allogeneic Universal Cell Therapy Market Share by Application (2021-2026)
Figure 25. Asia-Pacific Allogeneic Universal Cell Therapy Market Share by Type (2021-2026)
Figure 26. Asia-Pacific Allogeneic Universal Cell Therapy Market Share by Application (2021-2026)
Figure 27. Latin America Allogeneic Universal Cell Therapy Market Share by Type (2021-2026)
Figure 28. Latin America Allogeneic Universal Cell Therapy Market Share by Application (2021-2026)
Figure 29. Middle East & Africa Allogeneic Universal Cell Therapy Market Share by Type (2021-2026)
Figure 30. Middle East & Africa Allogeneic Universal Cell Therapy Market Share by Application (2021-2026)
Figure 31. Novartis Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 32. Gilead Sciences Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 33. Yi Zun Biology Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 34. Bangyao Biotechnology Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 35. Usano Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 36. Cellectis Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 37. Allogene Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 38. Caribou Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 39. Poseida Therapeutics Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 40. Keji Pharmaceutical Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 41. Beiheng Biotechnology Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 42. Grace Biotechnology Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 43. Nkarta Therapeutic Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 44. Fate Therapeutics Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 45. Ruishun Biology Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 46. Cynata Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 47. Fate Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 48. Century Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 49. Cytovia Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 50. BeiGene Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 51. Cell-Origin Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 52. Neukio Revenue Growth Rate in Allogeneic Universal Cell Therapy Business (2021-2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed